ArticleInfectious diseases and therapy2021

Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study.

Guanhao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.